A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

[Background and Aims] Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe subtype, metabolic dysfunction-associated steatohepatitis (MASH), are highly prevalent and strongly associated with obesity and type 2 diabetes (T2D). This study sought to identify challenges t...

Full description

Bibliographic Details
Authors: Castera, Laurent, Alazawi, William, Bugianesi, Elisabetta, Caussy, Cyrielle, Federici, Massimo, Romero-Gómez, Manuel, Schattenberg, Jörn M., Basuroy, Ron, Prasad, Preethy, Estulin, Dmitry, Lazarus, Jeffrey V.
Format: article
Status:Published version
Publication Date:2025
Country:España
Institution:Consejo Superior de Investigaciones Científicas (CSIC)
Repository:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/390353
Online Access:http://hdl.handle.net/10261/390353
https://api.elsevier.com/content/abstract/scopus_id/85214096193
Access Level:Open access
Keyword:MASH
MASLD
Cross‐sectional study
Liver disease
Obesity
Type 2 diabetes
Description
Summary:[Background and Aims] Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe subtype, metabolic dysfunction-associated steatohepatitis (MASH), are highly prevalent and strongly associated with obesity and type 2 diabetes (T2D). This study sought to identify challenges to the diagnosis, treatment and management of people living with MASLD and MASH and understand the key barriers to adopting relevant clinical guidelines.

Similar Items